Jessica Ponder

Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia

Shanshan Pei, Daniel A. Pollyea, Annika Gustafson et al. · Cancer Discovery · 2020 · 518 citations

Mixed-phenotype Acute Leukemia, Immunology, Pharmacotherapy +19

The Isolation and Characterization of β-Glucogallin as a Novel Aldose Reductase Inhibitor from Emblica officinalis

Puppala Muthenna, Jessica Ponder, Palla Suryanarayana et al. · PLoS ONE · 2012 · 106 citations · Full text

Polyphenolics, Biosynthesis, Aldo-keto Reductase +13

Beta-glucogallin reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues

Kun‐Che Chang, Brian Laffin, Jessica Ponder et al. · Chemico-Biological Interactions · 2012 · 51 citations

Inflammation, Metabolic Syndrome, Anti-inflammatory +13

Design of an Amide <i>N</i>-Glycoside Derivative of β-Glucogallin: A Stable, Potent, and Specific Inhibitor of Aldose Reductase

Linfeng Li, Kun‐Che Chang, Yaming Zhou et al. · Journal of Medicinal Chemistry · 2013 · 47 citations · Full text

Specific Inhibitor, New Linkages, Bioorganic Chemistry +16

MMB triazole analogs are potent NF-κB inhibitors and anti-cancer agents against both hematological and solid tumor cells

Venumadhav Janganati, Jessica Ponder, Meenakshisundaram Balasubramaniam et al. · European Journal of Medicinal Chemistry · 2018 · 47 citations · Full text

Tumor Biology, Oncology, Solid Tumor Cells +10